Table 2.
Data on hemodynamic, workload and test results
| Control group (without facemask) n = 116 |
COVID-19 era group (with facemask) n = 64 |
P | |
|---|---|---|---|
| Positive ESE | 19 (16.38) | 9 (14.06) | .681 |
| Peak systolic blood pressure, mmHg | 173.77 ± 25.82 | 181.81 ± 23.69 | .041* |
| Peak heart rate, bpm | 140.72 ± 22.32 | 146.84 ± 19.04 | .065 |
| Double product | 24 621.34 ± 6011.60 | 26 640.14 ± 4406.74 | .019* |
| MET | 8.76 ± 2.88 | 8.77 ± 2.69 | .984 |
| MET reached – MET predicted | 1.12 ± 2.31 | 1.16 ± 2.27 | .898 |
| Patients reaching predicted MET | 86 (74.14) | 44 (68.75) | .440 |
| Conclusive study | 76 (65.52) | 55 (85.94) | .003* |
ESE, exercise stress echocardiogram; MET, metabolic equivalents; Double product, peak systolic blood pressure x peak heart rate.
Data are expressed as No. (%) or mean ± standard deviation.
*
P < .05.